Melanoma – Newly Diagnosed or Recurrent Advanced (combination with pembrolizumab)| XPORT-MEL-033

Indication: Melanoma
Title: Safety and Efficacy of Selinexor in Combination With Pembrolizumab in Newly Diagnosed or Recurrent Advanced Melanoma
Drug: Selinexor

Please visit clinicaltrials.gov to learn more about this trial